Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pleiner

Showing results (101-110 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 10, 2006
Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetesDominik G Haider, Johannes Pleiner, Mario Francesconi, et al.
Calcified Tissue International|February 4, 2009
Treatment of osteoporosis with parathyroid hormone and teriparatideJohannes Pleiner-Duxneuner, Elisabeth Zwettler, Eleftherios Paschalis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearmAnna Rab, Susanne Dallinger, Kaija Polak, et al.
Shock (Augusta, Ga.)|November 20, 2003
Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humansClaudia Marsik, Thomas Halama, Francesco Cardona, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2008
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humansG Schaller, J Kolodjaschna, J Pleiner, et al.
European Journal of Clinical Investigation|August 20, 2003
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humansF Mittermayer, J Pleiner, G Schaller, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2011
Actovegin®: a biological drug for more than 5 decadesFlorian Buchmayer, Johannes Pleiner, Martin W Elmlinger, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 9, 2011
Chaotic dynamics of a magnetic nanoparticleJ Bragard, H Pleiner, O J Suarez, et al.
European Journal of Clinical Investigation|January 7, 2010
Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trialB B Heinisch, M Francesconi, F Mittermayer, et al.
Nitric Oxide : Biology and Chemistry|August 4, 2001
The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in menA Schmidt, M Bayerle-Eder, H Pleiner, et al.
Pageof 18

Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|August 10, 2006
Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetesDominik G Haider, Johannes Pleiner, Mario Francesconi, et al.
Calcified Tissue International|February 4, 2009
Treatment of osteoporosis with parathyroid hormone and teriparatideJohannes Pleiner-Duxneuner, Elisabeth Zwettler, Eleftherios Paschalis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearmAnna Rab, Susanne Dallinger, Kaija Polak, et al.
Shock (Augusta, Ga.)|November 20, 2003
Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humansClaudia Marsik, Thomas Halama, Francesco Cardona, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2008
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humansG Schaller, J Kolodjaschna, J Pleiner, et al.
European Journal of Clinical Investigation|August 20, 2003
Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humansF Mittermayer, J Pleiner, G Schaller, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2011
Actovegin®: a biological drug for more than 5 decadesFlorian Buchmayer, Johannes Pleiner, Martin W Elmlinger, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 9, 2011
Chaotic dynamics of a magnetic nanoparticleJ Bragard, H Pleiner, O J Suarez, et al.
European Journal of Clinical Investigation|January 7, 2010
Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trialB B Heinisch, M Francesconi, F Mittermayer, et al.
Nitric Oxide : Biology and Chemistry|August 4, 2001
The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in menA Schmidt, M Bayerle-Eder, H Pleiner, et al.
Pageof 18